Key Players Copernicus Therapeutics Inc , Grupo Ferrer Internacional SA, Iris Pharma
The latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration – Pipeline Review, H1 2017, provides an overview of the Juvenile Macular Degeneration (Ophthalmology) pipeline landscape.
Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form of juvenile macular degeneration is Stargardt disease. Stargardt’s disease is an inherited autosomal recessive syndrome. Signs and symptoms include blurry or fuzzy vision, dark, empty spots in the center of vision and difficulty reading or performing detail work. Risk factors include arteriosclerosis, hypercholesterolemia, smoking and hypertension.
Request a sample report @ https://www.htfmarketreport.com/sample-report/322002-juvenile-macular-degeneration